key: cord-1001657-4mvetnqe authors: nan title: Statement - COVID-19 Vaccination - Male and Female fertility, treatments to get pregnant, pregnancy date: 2022 journal: JBRA Assist Reprod DOI: 10.5935/1518-0557.20220018 sha: b6295941c172789efaa60f46ea2d46fdeef5bde3 doc_id: 1001657 cord_uid: 4mvetnqe nan More than two years into the SARS-CoV-2 pandemic, the effects of the virus on the male and female reproductive system remain controversial. On the one hand, men with active infection harbor the virus for a short period, from 2 to 11 days Holtmann et al., 2020) , symptoms eventually referred to reproduction organs can be simply attributed to hyperthermia and/or or hypoxia. Infections in remission showed the virus in the semen in 1.4% versus 6% of the cases evaluated in the active phase, not seeming to worsen the spermogram parameters. A single case described as a positive semen test at 21 days of recovery showed that the stable partner, under unprotected sex, tested negative with oropharyngeal, rectal and vaginal smears (Gacci et al., 2021) , indicating viral RNA and not a live virus active in the semen. In women, one can theoretically expect compromise of the ovary, uterus and vagina, as well as the endometrium and breasts, with menstrual disorders and secondary infertility (Jing et al., 2020) , effects that have also not been clear to date . A variety of vaccines for SARS-CoV-2 have been developed, at record speed, thanks to the efforts of the world scientific community, associated with some government and industry efforts (Garg et al., 2021) . However, the World Health Organization (WHO) has defined a situation of "vaccine hesitancy" (WHO, 2014), i.e., a delay or complete refusal to receive the vaccine, regardless of availability, with vaccines authorized through strict approval standards, with attenuated virus or m-RNA particles. Publications of false information that the incompletely inactivated virus or its particles have the potential ability to change the genetic information of an individual, could be introduced into the body, has negatively impacted patients who wish to become pregnant or even undergoing treatment to become pregnant, as well as pregnant women, lactating women and babies (Cha, 2021) . In this way, considering that: 1. More than 4 billion doses of vaccines have been given to date, the CDC-Vaccine Adverse Event Reporting System, among more than 72 million Americans vaccinated, has recorded a small number of mild menstrual disorders (NIH, 2021). had no influence on seminal parameters such as sperm concentration, seminal volume or sperm motility (Gonzalez et al., 2021; Safrai et al., 2022) . Likewise, follicular steroidogenesis and oocyte quality did not differ between vaccinated and non-vaccinated individuals (Bentov et al., 2021) . 3. Also, Orvieto et al. (2021) recording parameters of IVF cycles, also reported no difference between total and mature eggs retrieved, fertilization rates, and high-quality embryos. Aharon et al. (2022) complemented the information that nothing different was evidenced in relation to the rate of pregnancies and ongoing pregnancies, comparing vaccinated and non-vaccinated patients. 4. Preconception vaccination or vaccination before the 20 th week of pregnancy did not define a higher rate of spontaneous abortion in 2,456 pregnant women (Zauche et al., 2021) . 5. There were no descriptions of placental compromise, perinatal or postnatal changes related to mRNA vaccines (Shanes et al., 2021) , for women or their babies. 6. IgA levels were detected in nursing mothers at 2 weeks after vaccination, with IgG index increased at 4 weeks (one week after the second dose of mRNA vaccines), suggesting protection for the baby (Romero Ramírez et al., 2021) . 7. The severity of COVID-19 illness, risk of death and adverse obstetric outcomes, and growing data on vaccine safety and effectiveness during pregnancy should outweigh any potential for individual adverse effects to the woman or her child. The medical societies hereby represented recommend vaccination against the SARS-CoV-2 virus with the vaccine available, which should be encouraged with patients who are undergoing treatment to become pregnant, who are already pregnant, or even have recently given birth. To date, there is no evidence that the fertility potential of either men or women is affected by the use of vaccines. Vitro Fertilization and Early Pregnancy Outcomes After Coronavirus Disease 2019 (COVID-19) Vaccination. Obstet Gynecol. 2022. Epub ahead of print Hersko Klement A. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination False claims tying coronavirus vaccines to infertility drive doubts among women of childbearing age. The Washington Post Effects of COVID-19 and mRNA vaccines on human fertility Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines Sperm Parameters Before and After COVID-19 mRNA Vaccination Absence of SARS-CoV-2 in semen of a COVID-19 patient cohort Assessment of SARS-CoV-2 in human semen-a cohort study Potential influence of COVID-19/ACE2 on the female reproductive system Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age Notice of special interest (NOSI) to encourage administrative supplement applications to investigate COVID-19 vaccination and menstruation (Admin Supp -Clinical Trial Optional) Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? SARS-CoV-2 Antibodies in Breast Milk After Vaccination The BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters. Reprod Biomed Online. 2022. Epub ahead of print Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology Report of the SAGE working group on vaccine hesitancy CDC v-safe Covid-19 Pregnancy Registry Team. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion